Cargando…

von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage

Spontaneous intracerebral haemorrhage (ICH) is the most devastating stroke subtype and has no proven treatment. von Willebrand factor (VWF) has recently been demonstrated to promote inflammation processes. The present study investigated the pathophysiological role of VWF after experimental ICH. Func...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ximin, Cao, Yongliang, Wei, Lixiang, Cai, Ping, Xu, Haochen, Luo, Haiyu, Bai, Xiaofei, Lu, Lu, Liu, Jian-Ren, Fan, Wenying, Zhao, Bing-Qiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080593/
https://www.ncbi.nlm.nih.gov/pubmed/27782211
http://dx.doi.org/10.1038/srep35901
_version_ 1782462750843207680
author Zhu, Ximin
Cao, Yongliang
Wei, Lixiang
Cai, Ping
Xu, Haochen
Luo, Haiyu
Bai, Xiaofei
Lu, Lu
Liu, Jian-Ren
Fan, Wenying
Zhao, Bing-Qiao
author_facet Zhu, Ximin
Cao, Yongliang
Wei, Lixiang
Cai, Ping
Xu, Haochen
Luo, Haiyu
Bai, Xiaofei
Lu, Lu
Liu, Jian-Ren
Fan, Wenying
Zhao, Bing-Qiao
author_sort Zhu, Ximin
collection PubMed
description Spontaneous intracerebral haemorrhage (ICH) is the most devastating stroke subtype and has no proven treatment. von Willebrand factor (VWF) has recently been demonstrated to promote inflammation processes. The present study investigated the pathophysiological role of VWF after experimental ICH. Functional outcomes, brain edema, blood-brain barrier (BBB) permeability, cerebral inflammation and levels of intercellular adhesion molecule-1 (ICAM-1) and matrix metalloproteinase-9 (MMP-9) were measured in a mouse model of ICH induced by autologous blood injection. We show that VWF were increased in the plasma and was accumulated in the perihematomal regions of mice subjected to ICH. Injection of VWF resulted in incerased expression of proinflammatory mediators and activation of ICAM-1 and MMP-9, associated with elevated myeloperoxidase, recruitment of neutrophils and microglia. Moreover, mice treated with VWF showed dramatically decreased pericyte coverage, more severe BBB damage and edema formation, and neuronal injury was increased compared with controls. In contrast, blocking antibodies against VWF reduced BBB damage and edema formation and improved neurological function. Together, these data identify a critical role for VWF in cerebral inflammation and BBB damage after ICH. The therapeutic interventions targeting VWF may be a novel strategy to reduce ICH-related injury.
format Online
Article
Text
id pubmed-5080593
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-50805932016-10-31 von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage Zhu, Ximin Cao, Yongliang Wei, Lixiang Cai, Ping Xu, Haochen Luo, Haiyu Bai, Xiaofei Lu, Lu Liu, Jian-Ren Fan, Wenying Zhao, Bing-Qiao Sci Rep Article Spontaneous intracerebral haemorrhage (ICH) is the most devastating stroke subtype and has no proven treatment. von Willebrand factor (VWF) has recently been demonstrated to promote inflammation processes. The present study investigated the pathophysiological role of VWF after experimental ICH. Functional outcomes, brain edema, blood-brain barrier (BBB) permeability, cerebral inflammation and levels of intercellular adhesion molecule-1 (ICAM-1) and matrix metalloproteinase-9 (MMP-9) were measured in a mouse model of ICH induced by autologous blood injection. We show that VWF were increased in the plasma and was accumulated in the perihematomal regions of mice subjected to ICH. Injection of VWF resulted in incerased expression of proinflammatory mediators and activation of ICAM-1 and MMP-9, associated with elevated myeloperoxidase, recruitment of neutrophils and microglia. Moreover, mice treated with VWF showed dramatically decreased pericyte coverage, more severe BBB damage and edema formation, and neuronal injury was increased compared with controls. In contrast, blocking antibodies against VWF reduced BBB damage and edema formation and improved neurological function. Together, these data identify a critical role for VWF in cerebral inflammation and BBB damage after ICH. The therapeutic interventions targeting VWF may be a novel strategy to reduce ICH-related injury. Nature Publishing Group 2016-10-26 /pmc/articles/PMC5080593/ /pubmed/27782211 http://dx.doi.org/10.1038/srep35901 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Zhu, Ximin
Cao, Yongliang
Wei, Lixiang
Cai, Ping
Xu, Haochen
Luo, Haiyu
Bai, Xiaofei
Lu, Lu
Liu, Jian-Ren
Fan, Wenying
Zhao, Bing-Qiao
von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage
title von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage
title_full von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage
title_fullStr von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage
title_full_unstemmed von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage
title_short von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage
title_sort von willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080593/
https://www.ncbi.nlm.nih.gov/pubmed/27782211
http://dx.doi.org/10.1038/srep35901
work_keys_str_mv AT zhuximin vonwillebrandfactorcontributestopooroutcomeinamousemodelofintracerebralhaemorrhage
AT caoyongliang vonwillebrandfactorcontributestopooroutcomeinamousemodelofintracerebralhaemorrhage
AT weilixiang vonwillebrandfactorcontributestopooroutcomeinamousemodelofintracerebralhaemorrhage
AT caiping vonwillebrandfactorcontributestopooroutcomeinamousemodelofintracerebralhaemorrhage
AT xuhaochen vonwillebrandfactorcontributestopooroutcomeinamousemodelofintracerebralhaemorrhage
AT luohaiyu vonwillebrandfactorcontributestopooroutcomeinamousemodelofintracerebralhaemorrhage
AT baixiaofei vonwillebrandfactorcontributestopooroutcomeinamousemodelofintracerebralhaemorrhage
AT lulu vonwillebrandfactorcontributestopooroutcomeinamousemodelofintracerebralhaemorrhage
AT liujianren vonwillebrandfactorcontributestopooroutcomeinamousemodelofintracerebralhaemorrhage
AT fanwenying vonwillebrandfactorcontributestopooroutcomeinamousemodelofintracerebralhaemorrhage
AT zhaobingqiao vonwillebrandfactorcontributestopooroutcomeinamousemodelofintracerebralhaemorrhage